The 35 references in paper Ia. Proletov Iu., E. Saganova S., O. Galkina V., I. Zubina M., E. Bogdanova O., V. Sipovskii G., A. Smirnov V., Я. Пролетов Ю., Е. Саганова С., О. Галкина В., И. Зубина М., Е. Богданова О., В. Сиповский Г., А. Смирнов В. (2013) “РОЛЬ НЕКОТОРЫХ БИОМАРКЕРОВ В ОЦЕНКЕ ХАРАКТЕРА ХРОНИЧЕСКОГО ПОВРЕЖДЕНИЯ ПОЧЕК У ПАЦИЕНТОВ С ПЕРВИЧНЫМИ ГЛОМЕРУЛОПАТИЯМИ // THE ROLE OF SEVERAL BIOMARKERS IN ESTIMATION OF KIDNEY INJURY IN PATIENTS WITH PRIMARY GLOMERULOPATHIES” / spz:neicon:nefr:y:2013:i:1:p:60-69

1
Смирнов АВ, Каюков ИГ, Добронравов АВ, Кучер АГ. Острое повреждение почек и острая почечная недостаточность: некоторые уроки международных инициатив. Нефрология
(check this in PDF content)
2
08; 12 (3): 7-12 2. Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and metaanalysis. Am J Kidney Dis 2009; 54(6): 1012-1024
(check this in PDF content)
3
Zhang Z, Lu B, Sheng X et. al. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis 2012; 59(4): 590-2
(check this in PDF content)
4
Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney Journal 2012; 5(2): 102-108
(check this in PDF content)
5
Ратнер МЯ, Серов ВВ, Томилина НА. Ренальные дисфункции (клинико-морфологическая характеристика). Медицина, М., 1977
(check this in PDF content)
6
Schainuck LI, Striker GE, Cutler RE et al. Structural-functional correlations in renal diseases. Part II: the correlations. Hum Pathol 1970; 1(4):631-641
(check this in PDF content)
7
Bohle A, Mackensen-Haen S, VonGise et al. The consequences of tubule-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990; 186(1): 135-144
(check this in PDF content)
8
Fassett RG, Venuthurupalli SK, Gobe GC et. al. Biomarkers in chronic kidney disease: a review. Kidney Int 2011; 80(8): 806-821
(check this in PDF content)
9
Bolignano D, Lacquaniti A, Coppolino G et. al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4(2): 337-344
(check this in PDF content)
10
Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005; 67 (2): 404-419
(check this in PDF content)
11
Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150(9): 604-612.
(check this in PDF content)
12
Shemesh O, Golbetz H, Kriss JP et. al. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28(5): 830-838.
(check this in PDF content)
13
Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med 1988; 39: 465-490
(check this in PDF content)
14
Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38(10): 1933-1953
(check this in PDF content)
15
Dharnidharka VR, Kwong C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002; 40(2): 221–226
(check this in PDF content)
16
Willems D, Wolff F, Mekhali F et al. Cystatin C for early detection of renal impairment in diabetes. Clin Biochem 2009; 42(1-2): 108-110
(check this in PDF content)
17
Chudleigh RA, Ollerton RL, Dunseath G et al. Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. Diabetologia 2009; 52(7): 1274–1278
(check this in PDF content)
18
Pöge U, Gerhardt T, Stoffel-Wagner B et al. Cystatin Cbased calculation of glomerular filtration rate in kidney transplant recipients. Kidney Int 2006; 70(1): 204-210
(check this in PDF content)
19
Spanaus KS, Kollerits B, Ritz E et al. Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem 2010; 56(5): 740-749
(check this in PDF content)
20
Lai KN. Pathogenesis of IgA nephropathy. Nat Rev Nephrol 2012; 8 (5): 275-283
(check this in PDF content)
21
Hothöfer H. Molecular architecture of the glomerular slit diaphragm: lessons learnt for a better understanding of disease pathogenesis. Nephrol Dial Transplan 2007; 22(8): 2124-2128
(check this in PDF content)
22
Смирнов АВ. Лечение гломерулопатий циклоспорином: правильный подход с неверным обоснованием. Нефрология 2010; 14 (4): 9-22
(check this in PDF content)
23
Rantanen M, Palmen T, Patari A et al. Nephrin TRAP mice lack slit diaphragm and show fibrotic glomeruli and cystic tubular lesions. J Am Soc Nephro 2002; 13(6): 1586-1594
(check this in PDF content)
24
Forbes JM, Bonnet F, Russo LM et al. Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. J Hypertens 2002; 20(5): 985-992
(check this in PDF content)
25
Pätäri A, Forsblom C, Havana M et al. Nephrinuria in diabetic nephropathy of type 1 diabetes. Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 2003; 52(12): 2969-2974
(check this in PDF content)
26
Чеботарева НВ, Бобкова ИН, Козловская ЛВ. Нефринурия как показатель структурно-функциональных нарушений гломерулярного фильтра у больных с протеинурическими формами нефрита. Клиническая нефрология 2010; 4: 45-52
(check this in PDF content)
27
Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney International 2007; 71(10): 967–970
(check this in PDF content)
28
Schmidt-Ott KM. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury – where do we stand today? Nephrol. Dial. Transplant 2011; 26 (3): 762-764
(check this in PDF content)
29
Вельков ВВ. NGAL – «ренальный тропонин», ранний маркер острого повреждения почек: актуальность для нефрологии и кардиохирургии. Клинико-лабораторный консилиум 2011; 38(2): 90-100
(check this in PDF content)
30
Каюков ИГ, Смирнов АВ, Эмануэль ВЛ. Цистатин С в современной медицине. Нефрология 2012; 16 (1): 22-39
(check this in PDF content)
31
Conti M, Moutereau S, Zater M et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med 2006; 44(3): 288–291
(check this in PDF content)
32
Herget-Rosenthal S, van Wijk JA, Brocker-Preuss M et al. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem 2007; 40 (13-14): 946–951
(check this in PDF content)
33
Nejat M, Hill JV, Pickering J et al. Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplan 2011; 26 (5): 1553-1558
(check this in PDF content)
34
Thielemans N, Lauwerys R, Bernard A. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron 1994; 66(4): 453–458
(check this in PDF content)
35
Bolignano D, Coppolino G, Campo S et. al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant 2008; 23 (1): 414-416 Поступила в редакцию 27.12.2012 г.
(check this in PDF content)